Healthcare companies can register for the drug company’s new “marketplace,” which stocks key medications in short supply, according to a Feb. 14 post on X. The portfolio includes amoxicillin-potassium clavulanate, cefdinir, etoposide, capecitabine, irbesartan and budesonide inhalation.
Mr. Cuban has previously indicated a focus on injectables that often fall into shortage. The company is still building its $11 million drug manufacturing plant in Dallas, which is expected to also ease shortages.
More than 4,000 medications are available through the marketplace, Mr. Cuban told Becker’s, which serves hospitals, retail pharmacies, clinics, post-acute care facilities and surgery centers.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
